Authors:
GREIDANUS TBV
JANSSEN S
FRANKHUIJZENSIEREVOGEL JC
MAIGRET C
VANDEHEIJNING BJM
Citation: Tbv. Greidanus et al., EFFECT OF CENTRAL ADMINISTRATION OF THE KAPPA-OPIATE RECEPTOR AGONISTU-69.593 ON NEUROHYPOPHYSEAL HORMONE LEVELS IN BLOOD AND CEREBROSPINAL-FLUID, Neuropeptides, 30(5), 1996, pp. 452-455
Citation: Bjm. Vandeheijning et Tbv. Greidanus, THE EFFECT ON NEUROHYPOPHYSEAL HORMONE-RELEASE, DIURESIS AND ELECTROLYTE OUTPUT OF MU-OPIOID AND KAPPA-OPIOID AGONISTS, Neuroscience research communications, 15(1), 1994, pp. 11-20
Authors:
VANDEHEIJNING BJM
MAIGRET C
KOEKKOEKVANDENHERIK I
SMELIK WFE
GREIDANUS TBV
Citation: Bjm. Vandeheijning et al., DYNORPHIN-A AND VASOPRESSIN RELEASE IN THE RAT - A STRUCTURE-ACTIVITYSTUDY, Neuropeptides, 26(6), 1994, pp. 371-378
Authors:
VANDEWALLE JGJ
DONCKERWOLCKE RAMG
KOOMANS HA
BOER P
VANISSEL H
GREIDANUS TBV
DERKX F
Citation: Jgj. Vandewalle et al., REGULATION OF BLOOD-VOLUME (BV) IN CHILDREN WITH MINIMAL LESIONS NEPHROTIC SYNDROME (MLNS), Kidney international, 46(5), 1994, pp. 1470-1470
Citation: Tbv. Greidanus et A. Baars, THE ROLE OF ENDOGENOUS VASOPRESSIN AND OXYTOCIN IN RESTRICTED BRAIN-AREAS ON PASSIVE-AVOIDANCE BEHAVIOR, Neuroscience research communications, 13(3), 1993, pp. 133-142